JENNIFER ST LOUIS: Open Payments
NPI 1992582456 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,661 in 61 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,661
Food & beverage: $1,657Education: $4
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $465 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $297 |
| Alkermes, Inc. | 8 | $206 |
| Teva Pharmaceuticals USA, Inc. | 18 | $202 |
| Axsome Therapeutics, Inc. | 3 | $165 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 5 | $119 |
| Lundbeck LLC | 1 | $30 |
| Stryker Corporation | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: INGREZZA, CAPLYTA, ARISTADA, Auvelity, UZEDY, Qelbree, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
